Leukemia diagnostic kit targeting prohibitin gene and diagnostic method using same
US11339421B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2017 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Feb 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/166
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A leukemia diagnostic kit may be an RT-PCR kit enabling expression levels of prohibitin-1 and prohibitin-2 to be checked in a leukemia patient specimen, wherein the accuracy and the reproducibility of leukemia diagnosis of the kit are higher than those of a conventional RT-PCR kit, thereby being useful as a kit for diagnosing leukemia, examining residual lesions and evaluating therapeutic effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.